Clinical Trial Update: A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179) [Phase 1]

View source ↗

Summary

A Phase 1 Merck study evaluating a method to measure glucose-dependent insulin secretion in healthy male volunteers using MK-0431-179; the trial has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-0431-179

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2010-08-03